{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:17:42Z","timestamp":1790511462606,"version":"4.1.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,2,15]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>A validated 3-miRNA classifier can effectively predict progression from early- to advanced-stage MF and survival at time of diagnosis. This classifier outperforms existing clinical prognostic factors and paves the way for implementation of personalized treatment in MF.<\/jats:p>","DOI":"10.1182\/blood-2017-06-788950","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T15:15:14Z","timestamp":1512486914000},"page":"759-770","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":52,"title":["Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study"],"prefix":"10.1182","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3768-4146","authenticated-orcid":false,"given":"Lise M.","family":"Lindahl","sequence":"first","affiliation":[{"name":"Department of Dermatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Besenbacher","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Aarhus University, Aarhus, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne H.","family":"Rittig","sequence":"additional","affiliation":[{"name":"Department of Dermatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Celis","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Aarhus University, Aarhus, Denmark;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Willerslev-Olsen","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise M. R.","family":"Gjerdrum","sequence":"additional","affiliation":[{"name":"Department of Pathology, Zealand University Hospital, Roskilde, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorbj\u00f8rn","family":"Krejsgaard","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Johansen","sequence":"additional","affiliation":[{"name":"Department of Dermatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Litman","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Woetmann","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Odum","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-4508","authenticated-orcid":false,"given":"Lars","family":"Iversen","sequence":"additional","affiliation":[{"name":"Department of Dermatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10","key":"2019111912482839600_B1","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"21","key":"2019111912482839600_B2","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"issue":"19","key":"2019111912482839600_B3","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Girardi","year":"2004","journal-title":"N Engl J Med"},{"issue":"9616","key":"2019111912482839600_B4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(08)60420-1","article-title":"Mycosis fungoides and S\u00e9zary syndrome","volume":"371","author":"Hwang","year":"2008","journal-title":"Lancet"},{"issue":"31","key":"2019111912482839600_B5","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"issue":"18","key":"2019111912482839600_B6","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2019111912482839600_B7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaad.2014.03.044","article-title":"Subsequent cancers, mortality, and causes of death in patients with mycosis fungoides and parapsoriasis: a Danish nationwide, population-based cohort study","volume":"71","author":"Lindahl","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2019111912482839600_B8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","article-title":"European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome - update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur J Cancer"},{"issue":"6","key":"2019111912482839600_B9","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/bjd.12717","article-title":"A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides","volume":"170","author":"Ferrara","year":"2014","journal-title":"Br J Dermatol"},{"issue":"11","key":"2019111912482839600_B10","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/jdv.12299","article-title":"Genetic markers associated with progression in early mycosis fungoides","volume":"28","author":"Johnson","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"2019111912482839600_B11","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1158\/1078-0432.CCR-14-3322","article-title":"The use of transcriptional profiling to improve personalized diagnosis and management of cutaneous T-cell lymphoma (CTCL)","volume":"21","author":"Litvinov","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"13","key":"2019111912482839600_B12","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.ejca.2013.04.018","article-title":"A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome","volume":"49","author":"Benton","year":"2013","journal-title":"Eur J Cancer"},{"issue":"4","key":"2019111912482839600_B13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/leu.2013.281","article-title":"MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia","volume":"28","author":"D\u00edaz-Bey\u00e1","year":"2014","journal-title":"Leukemia"},{"issue":"13","key":"2019111912482839600_B14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S1470-2045(13)70491-1","article-title":"Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis","volume":"14","author":"Zhang","year":"2013","journal-title":"Lancet Oncol"},{"issue":"29","key":"2019111912482839600_B15","doi-asserted-by":"crossref","first-page":"45730","DOI":"10.18632\/oncotarget.10160","article-title":"STAT5 induces miR-21 expression in cutaneous T cell lymphoma","volume":"7","author":"Lindahl","year":"2016","journal-title":"Oncotarget"},{"issue":"22","key":"2019111912482839600_B16","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","article-title":"Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)","volume":"118","author":"Ralfkiaer","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111912482839600_B17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/exd.12161","article-title":"miR-155 is involved in tumor progression of mycosis fungoides","volume":"22","author":"Moyal","year":"2013","journal-title":"Exp Dermatol"},{"issue":"12","key":"2019111912482839600_B18","first-page":"7207","article-title":"MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma [published correction appears in Anticancer Res. 2015;35(2):1219]","volume":"34","author":"Ralfkiaer","year":"2014","journal-title":"Anticancer Res"},{"issue":"6","key":"2019111912482839600_B19","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"6","key":"2019111912482839600_B20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2019111912482839600_B21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/bioinformatics\/17.6.520","article-title":"Missing value estimation methods for DNA microarrays","volume":"17","author":"Troyanskaya","year":"2001","journal-title":"Bioinformatics"},{"issue":"4","key":"2019111912482839600_B22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","article-title":"The lasso method for variable selection in the Cox model","volume":"16","author":"Tibshirani","year":"1997","journal-title":"Stat Med"},{"issue":"28","key":"2019111912482839600_B23","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1038\/onc.2015.435","article-title":"MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas","volume":"35","author":"Kitadate","year":"2016","journal-title":"Oncogene"},{"issue":"7","key":"2019111912482839600_B24","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood-2009-12-256719","article-title":"MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential","volume":"116","author":"Ballabio","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111912482839600_B25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molonc.2011.02.003","article-title":"miRNA expression profiling of mycosis fungoides","volume":"5","author":"van Kester","year":"2011","journal-title":"Mol Oncol"},{"issue":"12","key":"2019111912482839600_B26","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"2019111912482839600_B27","doi-asserted-by":"crossref","first-page":"e1306618","DOI":"10.1080\/2162402X.2017.1306618","article-title":"Gene expression analysis in cutaneous T-cell lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators","volume":"6","author":"Litvinov","year":"2017","journal-title":"OncoImmunology"},{"issue":"4","key":"2019111912482839600_B28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","article-title":"Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides","volume":"126","author":"McGirt","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2019111912482839600_B29","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/jid.2014.487","article-title":"MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma","volume":"135","author":"Sandoval","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"9","key":"2019111912482839600_B30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.3370","article-title":"Genomic analysis of mycosis fungoides and S\u00e9zary syndrome identifies recurrent alterations in TNFR2","volume":"47","author":"Ungewickell","year":"2015","journal-title":"Nat Genet"},{"issue":"12","key":"2019111912482839600_B31","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ng.3444","article-title":"Genomic profiling of S\u00e9zary syndrome identifies alterations of key T cell signaling and differentiation genes","volume":"47","author":"Wang","year":"2015","journal-title":"Nat Genet"},{"issue":"20","key":"2019111912482839600_B32","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1182\/blood-2013-06-510578","article-title":"Comprehensive analysis of PTEN status in Sezary syndrome","volume":"122","author":"Cristofoletti","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2019111912482839600_B33","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1038\/cddis.2011.32","article-title":"MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in S\u00e9zary syndrome","volume":"2","author":"Narducci","year":"2011","journal-title":"Cell Death Dis"},{"issue":"12","key":"2019111912482839600_B34","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/cdd.2013.125","article-title":"The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease","volume":"20","author":"Mogilyansky","year":"2013","journal-title":"Cell Death Differ"},{"issue":"1","key":"2019111912482839600_B35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molonc.2013.09.001","article-title":"Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment","volume":"8","author":"Kjersem","year":"2014","journal-title":"Mol Oncol"},{"issue":"15","key":"2019111912482839600_B36","doi-asserted-by":"crossref","first-page":"20381","DOI":"10.18632\/oncotarget.7953","article-title":"MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"2019111912482839600_B37","first-page":"127","article-title":"MicroRNA-338-3p suppresses metastasis of lung cancer cells by targeting the EMT regulator Sox4","volume":"6","author":"Li","year":"2016","journal-title":"Am J Cancer Res"},{"issue":"2","key":"2019111912482839600_B38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/cam4.17","article-title":"Differential expression of miRNAs in the serum of patients with high-risk oral lesions","volume":"1","author":"Maclellan","year":"2012","journal-title":"Cancer Med"},{"issue":"10","key":"2019111912482839600_B39","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.7150\/jca.14616","article-title":"The role of Mir-148a in cancer","volume":"7","author":"Li","year":"2016","journal-title":"J Cancer"},{"issue":"3","key":"2019111912482839600_B40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1158\/1541-7786.MCR-13-0507","article-title":"miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a","volume":"12","author":"Guo","year":"2014","journal-title":"Mol Cancer Res"},{"issue":"3","key":"2019111912482839600_B41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2133.2004.06106.x","article-title":"BCL2 and JUNB abnormalities in primary cutaneous lymphomas","volume":"151","author":"Mao","year":"2004","journal-title":"Br J Dermatol"},{"issue":"9","key":"2019111912482839600_B42","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood.V95.9.2937.009k15_2937_2942","article-title":"Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN","volume":"95","author":"Scarisbrick","year":"2000","journal-title":"Blood"},{"issue":"3","key":"2019111912482839600_B43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2353\/jmoldx.2008.070153","article-title":"Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues","volume":"10","author":"Doleshal","year":"2008","journal-title":"J Mol Diagn"},{"issue":"4","key":"2019111912482839600_B44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0625.2012.01445.x","article-title":"Comparison of microRNA expression using different preservation methods of matched psoriatic skin samples","volume":"21","author":"L\u00f8vendorf","year":"2012","journal-title":"Exp Dermatol"},{"issue":"5","key":"2019111912482839600_B45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrg3198","article-title":"MicroRNA profiling: approaches and considerations","volume":"13","author":"Pritchard","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"10","key":"2019111912482839600_B46","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1261\/rna.642907","article-title":"Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples","volume":"13","author":"Xi","year":"2007","journal-title":"RNA"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/7\/759\/1407016\/blood788950.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/7\/759\/1407016\/blood788950.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T14:29:30Z","timestamp":1574173770000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/131\/7\/759\/39310\/Prognostic-miRNA-classifier-in-earlystage-mycosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,2,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-06-788950","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]}}}